The 20 articles comprised 14 unique double-blinded RCTs (seven involved the comparison of SGLT2-I with placebo and seven involved the comparison of GLP1-RA) that recruited patients with T2D and reported cardiovascular and/or renal outcomes by race, ethnicity or region (Table 1). Here, GCG is linked to type 2 diabetes mellitus.